If you are the investors looking for the business development of Vaccine Discovery and Development in China, WCV 2008 provides you perfect face2face opportunities through such overload innovators’ presentations and so much breakthrough showcases for your choose. You can not only go through the detail scientific and technological findings by those innovators’ descriptions, and report on the projects they are making progress in, you can also learn the infrastructure of investment of vaccine discovery projects from those coming worldwide through the roundtable discussions as the following:
1) Vaccine Discovery Roadmap - Where is the New Vaccine Discovery and Development Venture Frontier
2) Why Invest in China for your vaccination programs?
3) Who is Actively Investing & in What kind of drug discovery capacity in vaccine world?
4) How to Form Joint venture business with central/regional Government owned bio/pharmaceutical companies in different countries?
5) What are the hottest Vaccine Therapeutics R & D opportunities today and over the next 2-5 years?
6) Understanding How to be successful in vaccine discovery and development in Asia or developing countries;
7) How to Build a Global IP Portfolio in Vaccine Discovery Company;
8) Recent Success Stories and a Trend of New Vaccine Development to the Future.
9) Roles of Scholars and entrepreneurs in Vaccine Discovery in China/Asia
10) Will the technologies come from Academic Sources or from Academic Collaborations be commercialized globally?
11) What's proprietary in Asia academic Drug Innovation Institutions to support your vaccine R & D program?
12) How should Vaccine be commercialized, and by whom?
13) Who owns the I.P. of Vaccine Therapeutics, and how should it be commercialized?
14) What are the tax implications for investing in China for non-China investors in Vaccine Discovery?
15) Will Strategies in M & A (Mergers & Acquisitions) apply for New Vaccine Therapeutic Innovators in China ? and What will happen on the cross-border M&A scene in general over the next 2-5 years?
16) What Role will China Pharma & Biotech Companies Play in Vaccine Production beyond Generic Vaccine Supply ?
17) Who will lead the Merging and Acquisition trend in Vaccine Field?
18) What is the better strategy in M & A, based upon domestic partners or set footprint overseas?
19) What Bio or Pharma Therapeutic Business Models suitable for setting up across cultural New Vaccine Development Company in China
20) Will China and its investors & New Vaccine Innovators lead the way? Or will they merely be fast followers of foreign business and investing innovations?
21) How to Gain the Insight into the Investment Security in Vaccine Development?
22) How to Reduce Costs and Risk in Vaccine Innovative Entrepreneurs;
23) How to enter into Early Stage investment for Concept-Prof Vaccines?
24) Should Foreign Investors Seek Public Exits or Liquidity Events on Chinese Exchanges such as Hong Kong 's Hang Seng ? or direct go to IPO on NSDQ
25) Which Investors will lead the way in Vaccine Development?
26) The Successful Case Studies from Recent winners in therapeutic Human or Veterinary Vaccine Innovations
27) How to define Value-added Vaccine Production or R & D Outsourcing Business?
28) How to Add the Most Value in the Out-sourcing Equation in Biotech/Pharmaceutical Vaccine Discovery?
29) Where is the government heading in terms of allowing off-shore structures?
30) Current Trends in Seed & Early Stage Investing in Vaccine Therapeutic Discovery in China
31) Licensing Issues from Research Institutes and Universities for a potential Vaccine candidate?
32) How to translate overseas IP of Vaccine Technologies/Candidates/Products into business operations?
If you are interested in joining WCV 2008 to search potential projects or IP to invest and want to learn more from above mentioned topics or you want to lead a panel to showcase your successful story in vaccination world, please contact us. We won’t let you down. You will deem to receive respect and find the there are so much room to explore in ever increasing demand on supply of new and effective vaccines to so many life threatening diseases!
Contacts:
